ASPI

ASP Isotopes Inc. Enters Into Warrant Inducement Transaction for Approximately $5.5 Million in Gross Proceeds

Retrieved on: 
Tuesday, April 9, 2024
Isotope, Exercise, Sale, ASP, ASPI, Security (finance)

The Company believes the structure of this transaction will result in substantially less fees, costs and dilution than may occur in other capital raising transactions, such as an underwritten offering of common stock or a private placement priced at a discount.

Key Points: 
  • The Company believes the structure of this transaction will result in substantially less fees, costs and dilution than may occur in other capital raising transactions, such as an underwritten offering of common stock or a private placement priced at a discount.
  • “We took the opportunity to do this transaction because we view it as an attractive means of raising additional capital; $5.5 million for 1.225 million new warrants is effectively $4.50 per share with minimal transaction costs,” said Paul Mann, Chairman and CEO of ASP Isotopes.
  • The offering is expected to close on or about April 11, 2024.
  • The Company has agreed to file a registration statement with the SEC covering the resale of common shares issuable upon exercise of the New Warrants.

ASP Isotopes Inc. Enters Into a Contract with U.S.-Based Small Modular Reactor (SMR) Company for Project Focused on Engineering Design and Planning for Enrichment Facility for the Production of Advanced Nuclear Fuels

Retrieved on: 
Monday, April 8, 2024
Nuclear fusion, Isotope, Uranium, Small modular reactor, ASP, Carbon, SMR, HALEU, IEA, ASPI, Renewable energy

The advanced nuclear fuels required during the next fifty years are expected to differ significantly from those used in the last fifty years.

Key Points: 
  • The advanced nuclear fuels required during the next fifty years are expected to differ significantly from those used in the last fifty years.
  • Without these advanced nuclear fuels, the world stands little chance of meeting 2050 climate goals.
  • Specifically, many SMRs in the future will require HALEU (High Assay Low Enriched Uranium) and nuclear fusion will require Lithium-6.
  • To meet 2050 climate goals, this must occur with a zero increase in carbon emissions.

ASP Isotopes Inc. Enters Into Purchase Agreement With a Leading Semiconductor Company for the Supply of Highly Enriched Electronic Gases

Retrieved on: 
Monday, April 1, 2024
Isotope, Icelandic, Silane, Artificiality, Particle, Artificial intelligence, ASP, Silicon, Silicon tetrafluoride, Semiconductor, ASPI

WASHINGTON, April 01, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it has entered into a purchase agreement with an industry leader in the design and manufacturing of semiconductors. Under the terms of the agreement, ASP Isotopes expects to supply highly enriched silicon-28 to the customer for use in next-generation semiconductors. The product is expected to be supplied from the Company’s South African production facility and shipped to the customer in the USA during 2024.

Key Points: 
  • - Purchase agreement covers supply of highly enriched silicon-28, which is expected to be supplied in 2024.
  • -ASP Isotopes Inc. is in discussions with multiple semiconductor manufacturers regarding the supply of highly enriched isotopically pure electronic gases for next-generation semiconductors, anticipated to enable technologies such as quantum computing and artificial intelligence.
  • Under the terms of the agreement, ASP Isotopes expects to supply highly enriched silicon-28 to the customer for use in next-generation semiconductors.
  • Highly enriched silicon-28 is spin-free where qubits are protected from sources of decoherence that causes loss of quantum information(1).

ASP Isotopes Inc. Announces Signing of Purchase Agreement for Offering of Convertible Notes by Quantum Leap Energy

Retrieved on: 
Thursday, February 29, 2024
Regulation, Person, Isotope, Note, Sale, ASP, ASPI, Security (finance)

The offering of QLE Notes was oversubscribed and is expected to result in gross proceeds to QLE of greater than $20 million.

Key Points: 
  • The offering of QLE Notes was oversubscribed and is expected to result in gross proceeds to QLE of greater than $20 million.
  • The QLE Notes will mature on the fifth anniversary of the initial closing, unless converted in accordance with their terms prior to such date.
  • The closing of the QLE Notes offering is subject to the fulfillment or waiver of certain conditions contained in the purchase agreement.
  • No offering of the QLE Notes or the common equity securities of QLE deliverable upon conversion of the QLE Notes (if any) was made into the United States or to U.S. persons.

ASP Isotopes Inc. Announces Increase in Offering Size of Convertible Notes by Quantum Leap Energy

Retrieved on: 
Thursday, February 22, 2024
Regulation, Person, Isotope, Sale, ASP, ASPI, Security (finance)

WASHINGTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or “ASPI” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced today an increase to the size of the previously announced offering of convertible notes by its wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE”).

Key Points: 
  • WASHINGTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or “ASPI” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced today an increase to the size of the previously announced offering of convertible notes by its wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE”).
  • The Notes will mature on the fifth anniversary of the initial closing, unless converted in accordance with their terms prior to such date.
  • There can be no assurance that the Notes Offering will be consummated or, if consummated, QLE will sell the maximum principal amount of Notes offered.
  • This press release contains information about the pending Notes Offering, and there can be no assurance that such transaction will be completed.

ASP Isotopes Inc. Announces Proposed Offering of Convertible Notes by Quantum Leap Energy

Retrieved on: 
Monday, February 19, 2024
Regulation, Person, Isotope, Sale, ASP, ASPI, Security (finance)

WASHINGTON, Feb. 18, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or “ASPI” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced today its intention to commence an offering by its wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE”), of up to US$20 million aggregate principal amount of QLE’s convertible notes (the "Notes"), subject to market and other conditions (the "Notes Offering").

Key Points: 
  • WASHINGTON, Feb. 18, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or “ASPI” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced today its intention to commence an offering by its wholly-owned subsidiary, Quantum Leap Energy LLC ("QLE”), of up to US$20 million aggregate principal amount of QLE’s convertible notes (the "Notes"), subject to market and other conditions (the "Notes Offering").
  • The Notes will mature on the fifth anniversary of the initial closing, unless converted in accordance with their terms prior to such date.
  • There can be no assurance that the Notes Offering will be consummated or, if consummated, QLE will sell the maximum principal amount of Notes offered.
  • This press release contains information about the pending Notes Offering, and there can be no assurance that such transaction will be completed.

ASP Isotopes Inc. Provides Update on Plans to Spin-Out its Wholly Owned Subsidiary, Quantum Leap Energy

Retrieved on: 
Friday, February 16, 2024
Lithium, Engineering, Nickel, Uranium, Ytterbium, Isotope, SMR, Nuclear Energy Institute, ASP, Microsoft, Nuclear energy, ASPI, License, Void coefficient, HALEU, Uranium mining

WASHINGTON, Feb. 16, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or “ASPI” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, announced today an update on its previously disclosed intention to spin-out its wholly owned subsidiary, Quantum Leap Energy LLC (“QLE”), as a separate public company. ASPI is planning to list QLE on a national exchange and distribute a portion of QLE’s common equity to ASPI’s stockholders as of a future record date, anticipated to be completed by year-end, in each case subject to obtaining applicable approvals and consents and complying with applicable rules and regulations and public market trading and listing requirements.

Key Points: 
  • - ASP Isotopes plans to spin a portion of Quantum Leap Energy’s common equity to ASP Isotopes' stockholders as of a future record date, in a tax efficient manner.
  • - ASP Isotopes licenses rights to technology related to the enrichment of nuclear fuels to Quantum Leap Energy.
  • ASPI to receive a 10% perpetual royalty on all revenues of Quantum Leap Energy.
  • - ASPI and QLE continue to work with potential customers to help resolve the current nuclear fuel supply chain issues.

ASP Isotopes Inc. Provides Corporate Update

Retrieved on: 
Wednesday, January 10, 2024
Laser, ASPI, Isotope, ASP, Microsoft, Small modular reactor, FDA, HALEU, Rare-earth element

WASHINGTON, Jan. 10, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today provided a corporate update regarding the Company’s operations in Pretoria, South Africa.

Key Points: 
  • -Commenced the construction of the Company’s third isotope enrichment facility in South Africa, for the production of Ytterbium-176.
  • Expects the facility to have production capacity of kilogram quantities of 99.55% 176Yb, and to commence operations in 2025.
  • WASHINGTON, Jan. 10, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today provided a corporate update regarding the Company’s operations in Pretoria, South Africa.
  • Quantum Enrichment utilizes lasers and is intended to revolutionize isotope production of certain isotopes such as Ytterbium-176, Nickel-64, HALEU and Lithium-6.

ASP Isotopes Inc. Enters Into Memorandum of Understanding (MOU) With Second US-based Small Modular Reactor (SMR) Company To Supply High Assay Low Enriched Uranium (HALEU)

Retrieved on: 
Monday, November 27, 2023
SMR, ASPI, Government, Small modular reactor, Void coefficient, MOU, Isotope, Nuclear energy, HALEU, Uranium mining

WASHINGTON, Nov. 27, 2023 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it has signed a memorandum of understanding with a second US-based SMR (Small Modular Reactor) company to establish a facility for producing High Assay Low Enriched Uranium (HALEU), a critical fuel for next-generation nuclear reactors. The Company has received interest from potential customers totalling over $30 billion(1) of HALEU demand at recent market prices.

Key Points: 
  • This collaboration includes a plan for the SMR company to consider providing financial support for the development of a HALEU production facility.
  • -ASP Isotopes Inc. and its subsidiary, Quantum Leap Energy LLC (QLE), are in active discussions with various regulatory bodies and governments to determine the location for its first HALEU production facility.
  • Their aim is to supply commercial quantities of HALEU for SMRs by 2027.
  • The Company has received interest from potential customers totalling over $30 billion(1) of HALEU demand at recent market prices.

ASP Isotopes Inc. Enters Strategic Relationship With PET Labs Pharmaceuticals for the Distribution of Medical Isotopes

Retrieved on: 
Sunday, October 29, 2023
Science, Radionuclide, Radiopharmaceutical, GE HealthCare, Piper, DLA Piper, PET, Cyclotron, Growth, Isotope, DLA, SPECT, Nuclear medicine, African, Patient, ASPI, Medical imaging

PET Labs is a South African radiopharmaceutical operations company dedicated to nuclear medicine and the science of radiopharmaceutical production.

Key Points: 
  • PET Labs is a South African radiopharmaceutical operations company dedicated to nuclear medicine and the science of radiopharmaceutical production.
  • PET Labs focuses on the production of fluorinated radioisotopes and active pharmaceutical ingredients.
  • PET Labs currently operates a single cyclotron in Pretoria, South Africa.
  • The primary objective of the relationship is to expand into frontier markets where there is an undersupply of radioisotopes used in medical imaging.